2015
DOI: 10.1097/med.0000000000000184
|View full text |Cite
|
Sign up to set email alerts
|

Leptin applications in 2015

Abstract: Purpose of review To summarize previous and current advancements for leptin therapeutics, we described how leptin may be useful in leptin deficient states such as lipodystrophy, for which leptin was recently approved, and how it may be useful in the future for typical obesity. Recent findings The discovery of leptin in 1994 built the foundation for understanding the pathophysiology and treatment of obesity. Leptin therapy reverses morbid obesity related to congenital leptin deficiency and appears to effectiv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
77
1
6

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 180 publications
(87 citation statements)
references
References 112 publications
2
77
1
6
Order By: Relevance
“…The db/db mouse was selected because of its close representation to the phenotype observed in human diabetes and obesity. A feature of this model is hyperleptinemia from a mutation in the leptin receptor, rarely the culprit for the metabolic disturbances seen in human diabetes but nonetheless detected in diabetes 43. By including a dietary restriction component, we aimed to determine whether the defect in the OT–NP–NO system in the db/db heart could be prevented with ET.…”
Section: Discussionmentioning
confidence: 99%
“…The db/db mouse was selected because of its close representation to the phenotype observed in human diabetes and obesity. A feature of this model is hyperleptinemia from a mutation in the leptin receptor, rarely the culprit for the metabolic disturbances seen in human diabetes but nonetheless detected in diabetes 43. By including a dietary restriction component, we aimed to determine whether the defect in the OT–NP–NO system in the db/db heart could be prevented with ET.…”
Section: Discussionmentioning
confidence: 99%
“…Hyperinsulinemia is a cardinal phenotype of obesity that can also lead to dysregulation of leptin signaling in adipocytes that normally acts to suppress secretion of insulin from the pancreas [112]. Leptin signaling from adipocytes serves as peripheral satiety signal and chronic elevated levels of glucocorticoids can lead to hyperleptinemia as well as to leptin resistance [113], both phenotypes associated with obesity [114]. …”
Section: Possible Mechanisms By Which Stress Exposure Alters E2’s Actmentioning
confidence: 99%
“…Because this potential risk, blood pressure measurement assays were slated to be carried out immediately after efficacy testing. Although leptin treatment has since been shown to be inefficacious for weight loss in humans (16), it has been shown to have a role in the regulation of blood pressure (17). …”
Section: Resultsmentioning
confidence: 99%